Cancer Control Practices and Their Effect on the Cancer Burden

View the objectives of this area of research.

2008

Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, Ditommaso D, Karnaofski K, Gulati R, Penson DF, Feuer EJ. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control Mar 2008;19(2):175-81.

2007

Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer 1 May 2007;109(9):1877-86.

2006

Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr 2006;(36):7-15.

Yu B. Estimation of shared Gamma frailty models by a modified EM algorithm. Computational Statistics and Data Analysis 30 Jan 2006;50:436-74.

2005

Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ. Modeling the dissemination of mammography in the United States. Cancer Causes Control Aug 2005;16(6):701-12.

Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 1 Nov 2005;104(9):1840-8.

2004

Feuer EJ, Boer R, Holford TR. Developing and comparing population models for the early detection of cancer. Statistical Methods in Medical Research 2004;13:419-420.

Feuer EJ, Etzioni R, Cronin KA, Mariotto A. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res Dec 2004;13(6):421-42.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care Mar 2004;42(3):239-50.

Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med Feb 2004;19(2):146-55.

Shaw PA, Etzioni R, Zeliadt SB, Mariotto A, Karnofski K, Penson DF, Weiss NS, Feuer EJ. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States. Am J Epidemiol 1 Dec 2004;160(11):1059-69.

2003

Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev Mar 2003;22(1):25-38.

Verdecchia A, Mariotto A, Gatta G, Bustamante-Teixeira MT, Ajiki W. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer Jul 2003;39(11):1603-9.

2002

Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998. Urology Feb 2002;59(2):251-5.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 3 Jul 2002;94(13):981-90.

Feuer EJ, Mariotto A, Merrill R. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. Cancer 15 Aug 2002;95(4):870-80.

Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 6 Nov 2002;94(21):1626-34.

2001

Cronin KA, Krebs-Smith SM, Feuer EJ, Troiano RP, Ballard-Barbash R. Evaluating the impact of population changes in diet, physical activity, and weight status on population risk for colon cancer (United States). Cancer Causes Control May 2001;12(4):305-16.

Knopf KB, Warren JL, Feuer EJ, Brown ML. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc Nov 2001;54(5):563-71.

Potosky AL, Feuer EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001;23(1):181-6.

2000

Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 5 Jan 2000;92(1):77A-8.

1999

Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. Ethn Dis 1999;9(1):111-25.

Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 16 Jun 1999;91(12):1033-9.

Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 16 Jun 1999;91(12):1025-32.

Feuer EJ, Sheinfeld J, Bosl GJ. Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. J Natl Cancer Inst 19 May 1999;91(10):816-8.

Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 16 Jun 1999;91(12):1017-24.

Legler JM, Gloeckler Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality. J Natl Cancer Inst 1 Dec 1999;91(23):2050A-22051.

Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 18 Aug 1999;91(16):1382-90.

Merrill RM, Feuer EJ, Warren JL, Schussler N, Stephenson RA. Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. Am J Epidemiol 15 Oct 1999;150(8):848-60.

1998

Etzioni R, Cha R, Feuer EJ, Davidov O. Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol 15 Oct 1998;148(8):775-85.

Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control Oct 1998;9(5):519-27.

1997

Merrill RM, Brawley OW. Prostate cancer incidence and mortality rates among white and black men. Epidemiology Mar 1997;8(2):126-31.

1996

Bunin GR, Feuer EJ, Witman PA, Meadows AT. Increasing incidence of childhood cancer: report of 20 years experience from the greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol Jul 1996;10(3):319-38.

Merrill RM. Changes in the use of radical prostatectomy for treating prostate cancer in the USA. Lancet 5 Oct 1996;348(9032):963-4.

Merrill RM. Stat Bite: Trends in prostate cancer incidence. J Natl Cancer Inst 22 Nov 1996;88(22):1617.

Merrill RM. Trends in prostate cancer incidence and surgery (Stat Bite). J Natl Cancer Inst Apr 1996;88:403.

Merrill RM, Potosky AL, Feuer EJ. Changing trends in U.S. prostate cancer incidence rates. J Natl Cancer Inst 20 Nov 1996;88(22):1683-5.

1995

Feuer EJ. Incidence of testicular cancer in U.S. men (Stat bite). J Natl Cancer Inst 1995;87(6):405.

Wun LM, Feuer EJ, Miller BA. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control Mar 1995;6(2):135-44.

1994

Feuer EJ, Frey CM, Brawley OW, Nayfield SG, Cunningham JB, Geller NL, Bosl GJ, Kramer BS. After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. J Clin Oncol Feb 1994;12(2):368-77.

Miller BA, Feuer EJ, Hankey BF. The significance of the rising incidence of breast cancer in the United States. Important Adv Oncol 1994193-207.

1993

Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993;43(1):27-41.

1992

Coleman EA, Kessler LG, Wun LM, Feuer EJ. Trends in the surgical treatment of ductal carcinoma in situ of the breast. Am J Surg Jul 1992;164(1):74-6.

Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 15 Dec 1992;136(12):1423-36.

Miller BA, Feuer EJ, Hankey BF. Breast cancer. N Engl J Med 10 Dec 1992;327(24):1756-7.

1991

Feuer EJ, Miller BA. Stat Bite: Breast and Lung/Bronchus Cancers in U.S. Women by Geographic Area. J Natl Cancer Inst 1991;83(20):1437.

Frey CM, Hartman AM. Stat Bite: U.S. Trends in Melanoma Incidence and Mortality. J Natl Cancer Inst 1991;83(23):1705.

Kessler LG, Feuer EJ, Brown ML. Projections of the breast cancer burden to U.S. women: 1990-2000. Prev Med Jan 1991;20(1):170-82.

Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control Mar 1991;2(2):67-74.

Miller BA, Feuer EJ, Hankey BF. Trends in invasive breast cancer incidence among American women (Stat Bite). J Natl Cancer Inst 1991;83:678.

1990

Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst 17 Oct 1990;82(20):1624-8.

1989

Department of Health and Human Services. Comments of the Department of Health and Human Services on the General Accounting Office`s Draft Report on Breast Cancer: Patients have yet to realize the benefits of adjuvant chemotherapy. In: Breast Cancer Patients` Survival. Washington D.C.: U.S. General Accounting Office; Feb 1989. p. 34-51.

1988

Brown CC, Kessler LG. Projections of lung cancer mortality in the United States: 1985-2025. J Natl Cancer Inst 2 Mar 1988;80(1):43-51.

1986

Levin DL, Gail MH, Kessler LG, Eddy DM. A model for projecting cancer incidence and mortality in the presence of prevention screening, and treatment programs. Cancer control objectives for the nation: 1985-2000. NCI Monographs Number 2. 1986. NIH Pub. No.86-2880.